These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early hepatocellular carcinoma and dysplastic nodules. Kojiro M, Roskams T. Semin Liver Dis; 2005; 25(2):133-42. PubMed ID: 15918142 [Abstract] [Full Text] [Related]
3. Liver precancerous lesions and hepatocellular carcinoma: the histology report. Roncalli M, Terracciano L, Di Tommaso L, David E, Colombo M, Gruppo Italiano Patologi Apparato Digerente (GIPAD), Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Dig Liver Dis; 2011 Mar; 43 Suppl 4():S361-72. PubMed ID: 21459342 [Abstract] [Full Text] [Related]
4. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Kojiro M. Liver Transpl; 2004 Feb; 10(2 Suppl 1):S3-8. PubMed ID: 14762831 [Abstract] [Full Text] [Related]
5. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Roskams T, Kojiro M. Semin Liver Dis; 2010 Feb; 30(1):17-25. PubMed ID: 20175030 [Abstract] [Full Text] [Related]
7. [Pathomorphologic characteristics and differential diagnosis of small hepatocellular carcinoma]. Nakashima O, Kojiro M. Gan To Kagaku Ryoho; 1996 Jun; 23(7):827-34. PubMed ID: 8678529 [Abstract] [Full Text] [Related]
10. Pathology of early hepatocellular carcinoma: progression from early to advanced. Kojiro M. Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1203-5. PubMed ID: 9730375 [Abstract] [Full Text] [Related]
11. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119 [Abstract] [Full Text] [Related]
12. Histopathology of liver cancers. Kojiro M. Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):39-62. PubMed ID: 15757804 [Abstract] [Full Text] [Related]
13. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. Muhi A, Ichikawa T, Motosugi U, Sano K, Matsuda M, Kitamura T, Nakazawa T, Araki T. J Magn Reson Imaging; 2009 Nov; 30(5):1005-11. PubMed ID: 19856432 [Abstract] [Full Text] [Related]
14. Liver biopsy in the diagnosis of hepatocellular carcinoma. Wanless IR. Clin Liver Dis; 2005 May; 9(2):281-5, vii. PubMed ID: 15831273 [Abstract] [Full Text] [Related]
15. Early hepatocellular carcinoma: pathology, imaging, and therapy. Takayama T, Makuuchi M, Kojiro M, Lauwers GY, Adams RB, Wilson SR, Jang HJ, Charnsangavej C, Taouli B. Ann Surg Oncol; 2008 Apr; 15(4):972-8. PubMed ID: 18236118 [Abstract] [Full Text] [Related]
16. 'Nodule-in-nodule' appearance in hepatocellular carcinoma: its significance as a morphologic marker of dedifferentiation. Kojiro M. Intervirology; 2004 Apr; 47(3-5):179-83. PubMed ID: 15383727 [Abstract] [Full Text] [Related]
17. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [Abstract] [Full Text] [Related]